These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

79 related items for PubMed ID: 26015218

  • 1. [Fixed combination improves compliance].
    Hubert M.
    MMW Fortschr Med; 2015 Apr 02; 157(6):70. PubMed ID: 26015218
    [No Abstract] [Full Text] [Related]

  • 2. [Effective blood pressure control with a fixed combination].
    Bäurle A.
    MMW Fortschr Med; 2016 May 25; 158(10):84. PubMed ID: 27221444
    [No Abstract] [Full Text] [Related]

  • 3. [Antihypertensive therapy in routine practice: fixed or free combination? Fixed combination scores with better prognosis].
    MMW Fortschr Med; 2011 Sep 01; 153(35):46-7. PubMed ID: 21916307
    [No Abstract] [Full Text] [Related]

  • 4. Amlodipine + valsartan + hydrochlorothiazide. A 3-drug fixed-dose combination for hypertension: too many drawbacks.
    Prescrire Int; 2011 Mar 01; 20(114):67. PubMed ID: 21648225
    [No Abstract] [Full Text] [Related]

  • 5. Valsartan-amlodipine-hydrochlorothiazide: the definitive fixed combination?
    Barrios V, Escobar C.
    Expert Rev Cardiovasc Ther; 2010 Nov 01; 8(11):1609-18. PubMed ID: 21090936
    [Abstract] [Full Text] [Related]

  • 6. Triple fixed-dose combination therapy: back to the past.
    Black HR.
    Hypertension; 2009 Jul 01; 54(1):19-22. PubMed ID: 19470871
    [No Abstract] [Full Text] [Related]

  • 7. [Hypertension. Guidelines recommend fixed combinations].
    MMW Fortschr Med; 2014 Apr 17; 156(7):62-3. PubMed ID: 24956662
    [No Abstract] [Full Text] [Related]

  • 8. Exforge HCT.
    Med Lett Drugs Ther; 2009 Jun 15; 51(1314):47. PubMed ID: 19528888
    [No Abstract] [Full Text] [Related]

  • 9. Efficacy and tolerability of combination therapy with valsartan plus hydrochlorothiazide compared with amlodipine monotherapy in hypertensive patients with other cardiovascular risk factors: the VAST study.
    Ruilope LM, Malacco E, Khder Y, Kandra A, Bönner G, Heintz D.
    Clin Ther; 2005 May 15; 27(5):578-87. PubMed ID: 15978306
    [Abstract] [Full Text] [Related]

  • 10. Targeting hypertension with valsartan: Lessons learned from the Valsartan/HCTZ versus Amlodipine in stage II hypertensive patients (VASt) trial.
    Ruilope LM, Zanchetti A.
    J Renin Angiotensin Aldosterone Syst; 2006 Jun 15; 7 Suppl 1():S8-11. PubMed ID: 16986228
    [Abstract] [Full Text] [Related]

  • 11. Adherence with multiple-combination antihypertensive pharmacotherapies in a US managed care database.
    Jackson KC, Sheng X, Nelson RE, Keskinaslan A, Brixner DI.
    Clin Ther; 2008 Aug 15; 30(8):1558-63. PubMed ID: 18803997
    [Abstract] [Full Text] [Related]

  • 12. Amlodipine/valsartan/hydrochlorothiazide triple combination therapy in moderate/severe hypertension: Secondary analyses evaluating efficacy and safety.
    Calhoun DA, Crikelair NA, Yen J, Glazer RD.
    Adv Ther; 2009 Nov 15; 26(11):1012-23. PubMed ID: 20024680
    [Abstract] [Full Text] [Related]

  • 13. Randomized, double-blinded trial evaluation of valsartan/hydrochlorothiazide combination therapy in mild to moderate essential hypertension in north-east China.
    Mualin I.
    J Int Med Res; 2009 Nov 15; 37(1):277. PubMed ID: 19215702
    [No Abstract] [Full Text] [Related]

  • 14. Valsartan/hydrochlorothiazide: pharmacology and clinical efficacy.
    Kondrack R, Mohiuddin S.
    Expert Opin Drug Metab Toxicol; 2009 Sep 15; 5(9):1125-34. PubMed ID: 19689218
    [Abstract] [Full Text] [Related]

  • 15. Two amlodipine/ARB combinations for hypertension.
    Med Lett Drugs Ther; 2007 Dec 17; 49(1276):101-2. PubMed ID: 18084152
    [No Abstract] [Full Text] [Related]

  • 16. [Blood pressure lowering and risk reduction under treatment with valsartan and its combination with hydrochlorothiazide (HCT)].
    Scholze J, Müller U.
    MMW Fortschr Med; 2006 Oct 19; 148(42):48. PubMed ID: 17621800
    [No Abstract] [Full Text] [Related]

  • 17. Comparison of real-world adherence, healthcare resource utilization and costs for newly initiated valsartan/amlodipine single-pill combination versus angiotensin receptor blocker/calcium channel blocker free-combination therapy.
    Baser O, Andrews LM, Wang L, Xie L.
    J Med Econ; 2011 Oct 19; 14(5):576-83. PubMed ID: 21728914
    [Abstract] [Full Text] [Related]

  • 18. [Effects of valsartan combined with amlodipine or hydrochlorothiazide regimen on blood pressure variation in elderly hypertensive patients].
    Wu ZB, Zhang Y, Yu QG, Sun CX, Tao CW.
    Zhonghua Xin Xue Guan Bing Za Zhi; 2012 Jan 19; 40(1):8-13. PubMed ID: 22490626
    [Abstract] [Full Text] [Related]

  • 19. Effectiveness of the fixed-dose combination of olmesartan/amlodipine/hydrochlorothiazide for the treatment of hypertension in patients stratified by age, race and diabetes, CKD and chronic CVD.
    Chrysant SG.
    Expert Rev Cardiovasc Ther; 2013 Sep 19; 11(9):1115-24. PubMed ID: 24073676
    [Abstract] [Full Text] [Related]

  • 20. [VALUE study underscores the significance of reaching aimed blood pressure values for minimizing cardiovascular risks].
    Praxis (Bern 1994); 2004 Oct 13; 93(42):1748. PubMed ID: 15529964
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.